Media Summary: Sara Tolaney, MD, MPH, Dana Farber Cancer Institute, Boston, MA, discusses the Tiffany Traina, MD, reviews clinical trials APHINITY and KATHERINE, and how they affect her recommendations for treatment of ... An overview of the updated NCCN (National Comprehensive Cancer Center)
Current Standards For Her2 Early - Detailed Analysis & Overview
Sara Tolaney, MD, MPH, Dana Farber Cancer Institute, Boston, MA, discusses the Tiffany Traina, MD, reviews clinical trials APHINITY and KATHERINE, and how they affect her recommendations for treatment of ... An overview of the updated NCCN (National Comprehensive Cancer Center) Denise A. Yardley, MD, reviews the available neoadjuvant approaches for treating patients with Elisa Agostinetto, MD, Istituto Clinico Humanitas, Rozzano, Milan, Italy, discusses an analysis of the prognostic performance of ... During this session, hear our speakers provide treatment updates, suggest what to look for in the future, and discuss how far we ...
Denise A. Yardley, MD, considers the diagnostic and prognostic workup of a 56-year-old woman who presents with Panelists Adam M. Brufsky, MD, PhD; Kimberly L. Blackwell, MD; Mark E. Robson, MD; and Aditya Bardia, MD, MPH, highlight the ... Panelists discuss their neoadjuvant and adjuvant treatment approaches for Breast cancer specialists, Dr Carlos Barrios, Prof. Dr. med. Nadia Harbeck & Prof. Chiun-Sheng Huang share their perspectives ... Please visit www.answersincme.com/101385133860 to participate, download slides and supporting materials, complete the ...
